Skip to content

Apotheek De Sutter Isabel: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek De Sutter Isabel

BE 0697.940.734
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€227,041
2024 · €222,201+€4,840
Equity
€32,726
2024 · €25,685+€7,041
Cash
€119,943
2024 · €241,831-€121,888
Balance sheet total
€828,818
2024 · €1.1m-€237,938

Largest movements

2024 to 2025
Assets
  • Cash -€121,888

    down €121,888 (-50.4%), from €241,831 to €119,943

    mainly Contributions, distributions and other (-€220,000) and Other debts (-€137,287)

  • Intangible fixed assets -€58,000

    down €58,000 (-25.0%), from €232,000 to €174,000

  • Tangible fixed assets -€34,464

    down €34,464 (-15.1%), from €228,366 to €193,902

    of which Plant, machinery and equipment: -€32,550

  • Current investments -€11,120

    down €11,120 (-100%), from €11,120 to €0

Equity and liabilities
  • Other debts -€137,287

    down €137,287 (-26.7%), from €513,272 to €375,984

  • Debts after one year -€88,654

    down €88,654 (-29.4%), from €301,429 to €212,775

  • Trade debts -€23,815

    down €23,815 (-22.0%), from €108,441 to €84,626

Income statement
  • Staff costs +€70,868

    up €70,868 (+95.7%), from €74,016 to €144,884

  • Gross operating margin +€68,479

    up €68,479 (+14.4%), from €477,047 to €545,527

  • Financial charges -€10,653

    down €10,653 (-59.7%), from €17,840 to €7,186

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €222,201
Gross operating margin +€68,479
Staff costs -€70,868
Depreciation -€3,899
Other operating charges -€521
Financial income +€1,898
Financial charges +€10,653
Taxes -€904
Result 2025 €227,041
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€179,364
Investment +€6,105
Financing -€307,358
Cash 2024 €241,831
Net result for the year +€227,041
Depreciation +€97,479
Stocks and contracts +€8,706
Receivables within one year -€2,586
Deferred charges and accrued income +€6,346
Trade debts -€23,815
Tax, wage and social debts +€9,262
Other debts -€137,287
Accrued charges and deferred income -€5,780
Investment in fixed assets (net) -€5,015
Current investments +€11,120
Debts after one year -€88,654
Current portion of long-term debt +€1,296
Contributions, distributions and other -€220,000
Cash 2025 €119,943
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,066,756 €828,818 -€237,938 -22.3%
Fixed assets 21/28 €460,367 €367,903 -€92,464 -20.1%
Intangible fixed assets 21 €232,000 €174,000 -€58,000 -25.0%
Tangible fixed assets 22/27 €228,366 €193,902 -€34,464 -15.1%
Plant, machinery and equipment 23 €220,511 €187,961 -€32,550 -14.8%
Furniture and vehicles 24 €7,855 €5,941 -€1,914 -24.4%
Current assets 29/58 €606,390 €460,916 -€145,474 -24.0%
Stocks and contracts in progress 3 €228,757 €220,050 -€8,706 -3.8%
Stocks 30/36 €228,757 €220,050 -€8,706 -3.8%
Amounts receivable within one year 40/41 €114,439 €117,026 +€2,586 +2.3%
Trade receivables 40 €114,439 €117,026 +€2,586 +2.3%
Other amounts receivable 41 €0 - =
Current investments 50/53 €11,120 €0 -€11,120 -100%
Cash at bank and in hand 54/58 €241,831 €119,943 -€121,888 -50.4%
Deferred charges and accrued income 490/1 €10,243 €3,897 -€6,346 -62.0%
Total equity and liabilities 10/49 €1,066,756 €828,818 -€237,938 -22.3%
Equity 10/15 €25,685 €32,726 +€7,041 +27.4%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €7,085 €14,126 +€7,041 +99.4%
Distributable reserves 133 €7,085 €14,126 +€7,041 +99.4%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €1,041,072 €796,092 -€244,979 -23.5%
Amounts payable after more than one year 17 €301,429 €212,775 -€88,654 -29.4%
Financial debts 170/4 €301,429 €212,775 -€88,654 -29.4%
Amounts payable within one year 42/48 €733,862 €583,317 -€150,544 -20.5%
Current portion of amounts payable after more than one year 42 €87,358 €88,654 +€1,296 +1.5%
Trade debts 44 €108,441 €84,626 -€23,815 -22.0%
Suppliers 440/4 €108,441 €84,626 -€23,815 -22.0%
Taxes, remuneration and social security 45 €24,791 €34,052 +€9,262 +37.4%
Taxes 450/3 €10,251 €9,022 -€1,229 -12.0%
Remuneration and social security 454/9 €14,540 €25,031 +€10,491 +72.2%
Other amounts payable 47/48 €513,272 €375,984 -€137,287 -26.7%
Accrued charges and deferred income 492/3 €5,780 €0 -€5,780 -100%
Remuneration, social security and pensions 62 €74,016 €144,884 +€70,868 +95.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €93,580 €97,479 +€3,899 +4.2%
Other operating charges 640/8 €159 €679 +€521 +328%
Gross operating margin 9900 €477,047 €545,527 +€68,479 +14.4%
Operating profit (loss) 9901 €309,293 €302,484 -€6,808 -2.2%
Financial income 75/76B €1,003 €2,902 +€1,898 +189%
Recurring financial income 75 €1,003 €2,902 +€1,898 +189%
Financial charges 65/66B €17,840 €7,186 -€10,653 -59.7%
Recurring financial charges 65 €17,840 €7,186 -€10,653 -59.7%
Profit (loss) for the period before taxes 9903 €292,456 €298,200 +€5,743 +2.0%
Income taxes 67/77 €70,255 €71,159 +€904 +1.3%
Profit (loss) for the period 9904 €222,201 €227,041 +€4,840 +2.2%
Profit (loss) for the period to be appropriated 9905 €222,201 €227,041 +€4,840 +2.2%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.